Navigation Links
AstraZeneca's Rich Fante Elected as National Pharmaceutical Council's Chairman of the Board
Date:10/28/2011

WASHINGTON, Oct. 28, 2011 /PRNewswire-USNewswire/ -- The National Pharmaceutical Council (NPC) today announced that Rich Fante, President, AstraZeneca U.S. and CEO North America, has been elected Chairman of its Board of Directors for 2011-12. Mr. Fante has served on NPC's Board since 2008, most recently as Treasurer.

"Rich takes the helm at a time when the health care landscape is continuing to change at a rapid pace. As someone with tremendous experience in the pharmaceutical industry, Rich understands how NPC's policy research can help inform decision-making among those shaping the future of health care delivery," said NPC President Dan Leonard.

"During my chairmanship, I'm looking forward to leading NPC as it positions itself for the future," said Mr. Fante. "NPC has an important and unique role to play in supporting the development and application of comparative effectiveness research and other data important to improving health outcomes.  By engaging with providers, payers, policymakers and other stakeholders, NPC will be able to meaningfully contribute to shaping the health care environment."

Prior to his current role at AstraZeneca, Mr. Fante served as the company's Vice President, Brand Strategy and Portfolio Operations.  He led the development and execution of marketing strategies for all AstraZeneca brands in the United States.  He has held a number of leadership roles at AstraZeneca, including Vice President—Primary Care for the gastrointestinal and respiratory franchises. Outside of AstraZeneca, Mr. Fante serves as a member of the Roundtable on Value & Science-Driven Health Care for the Institute of Medicine.

Mr. Leonard also recognized the efforts of the outgoing chair, Kevin T. Rigby, Vice President of Public Affairs and Communications at Novartis Pharmaceuticals Corporation, who will remain active on NPC's Board. "Under Kevin's leadership, we made great strides in increasing NPC's awareness and visibility with key CER stakeholders, as well as improving our infrastructure and business operations. We greatly appreciated his involvement in strengthening the organization," said Mr. Leonard.

The NPC Board also elected John Gargiulo, President and CEO of Daiichi Sankyo, Inc., to serve as its Vice Chairman, and Jeff Huth, Senior Vice President, Managed Markets, of Boehringer Ingelheim Pharmaceuticals, Inc., as Treasurer.  

About the National Pharmaceutical Council

The National Pharmaceutical Council is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation. Founded in 1953 and supported by the nation's major research-based pharmaceutical companies, NPC focuses on research development, information dissemination, and education on the critical issues of evidence, innovation and the value of medicines for patients. For more information, visit www.npcnow.org.  


'/>"/>
SOURCE National Pharmaceutical Council
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomas Dietz, Ph.D., Elected Chairman of Galleon Pharmaceuticals
2. Prasco® Selected as Eli Lilly and Companys Authorized Generics Partner
3. Prasco Named Exclusive U.S. Distributor for Selected Aspen Branded Products
4. Christine Pierre Selected as "Professional Woman of the Year"
5. Ikaria® CEO Daniel Tasse Elected to PhRMA Board of Directors
6. Dr. Paul Farmer Selected as 2011 Pro Bono Humanum Honoree by Prix Galien USA
7. Coloplast Selected By LifeScience Alley to Host Minnesota Medical Device Panel
8. BioSurplus Selected to Auction $10 Million in Lab Equipment
9. Linet Multicare® Hospital Bed Selected to Participate in National Program Highlighting Commitment to Healthcare Performance Improvement, Innovation
10. Dr. Jay Yadav, CardioMEMS Founder & CEO, Selected as a Finalist for 2011 Business Person of the Year Award
11. Selected Value Therapeutics Exercises Right to Develop and Commercialize ENMD-2076 in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... , Feb. 5, 2016 Dehaier Medical ... or the "Company"), which develops, markets and sells ... China and international markets, ... which aims to concentrate the Company,s resources to ... respiratory business and to focus more on its ...
(Date:2/5/2016)... Site Profile: --> Site ... People, announced their latest primary healthcare case study where speech recognition ... and to save the practice money. Site Profile: ... Challenge: --> ,- Wirral CCG ,- VoicePower client since ... Wirral CCG ,- VoicePower client since 2013 Challenge: ...
(Date:2/4/2016)... Feb. 4, 2016  Edwards Lifesciences Corporation (NYSE: ... structural heart disease and critical care monitoring, announced today ... (ASR) agreement with Morgan Stanley & Co. LLC to ... is part of the Company,s previously authorized program to ... stock.  --> --> ...
Breaking Medicine Technology:
(Date:2/5/2016)... , ... February 05, 2016 , ... The event is ... Day Block Event Center in Minneapolis, Minn. Triumph Over Parkinson’s will fund nearly $100,000 ... owner of Schneiderman’s Furniture, lives with Parkinson’s disease and is the architect of this ...
(Date:2/5/2016)... ... 05, 2016 , ... Freed-Hardeman University President Joe A. Wiley ... joint enrollment and degree completion agreement. The agreement, which begins with the ... FHU|Dickson. , The agreement allows students to be jointly admitted to both ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... franchises from across the country gathered at the La Valencia Hotel in San ... PROSHRED Chicago was named the year’s most outstanding franchise, walking away with ...
(Date:2/5/2016)... ... ... Boar’s Head Brand®, one of the nation’s leading providers of premium delicatessen ... stress out of your party preparation – follow these easy, yet delicious recipes with ... game. , “The key to hosting a successful game-day party is creating a flavorful ...
(Date:2/5/2016)... ... ... Stuart Bentkover, MD, FACS is thrilled to announce the arrival ... tattoo removal today, Dr. Bentkover is the only doctor in Central Massachusetts to offer ... been approved by the Food and Drug Administration (FDA) as a safe and efficient ...
Breaking Medicine News(10 mins):